-
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
Study
EGAS00001004953
-
GCP study
Study
EGAS00001004959
-
Sequencing of cell-free DNA from breast cancer patients
Study
EGAS00001004960
-
Cell-free DNA TAPS for early cancer detection
Study
EGAS00001004962
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Preliminary Results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT 2) Study
Study
EGAS00001004964
-
Evaluation of capture and amplicon-based targeted sequencing methods on formalin-fixed tumours
Study
EGAS00001004965
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
DO NOT USE - Whole genome sequencing of SI-NETs from six patients
Study
EGAS00001005009
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Study
EGAS00001005023
-
MicroRNA profiling by next-generation sequencing for colorectal cancer screening
Study
EGAS00001005030
-
Genomic Study of Gastric Cancer
Study
EGAS00001005032
-
Subtype-associated epigenomic landscape and 3D genome structure in bladder cancer
Study
EGAS00001005071
-
hereditary BrEAst Case CONtrol study
Study
EGAS00001005043
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Molecular analysis of inflammatory myofibroblastic tumor (WGS and WES)
Study
EGAS00001005081